NASDAQ:IMV
Delisted
IMV Inc. Stock News
$0.82
+0 (+0%)
At Close: Jul 27, 2023
IMV Inc. to Present at Two Upcoming Investor Conferences
07:05am, Monday, 04'th Apr 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platf
IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript
02:34pm, Thursday, 17'th Mar 2022
IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript
IMV Inc. to Announce Fourth Quarter and Fiscal Year 2021 Results and Host a Conference Call and Webcast on March 17, 2022
07:05am, Thursday, 10'th Mar 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. to Announce Fourth Quarter and Fiscal Year 2021 Results and Host a Conference Call and Webcast on March 17, 2022
IMV to Host a Webcast to Highlight its Immune-Educating DPX® Platform
07:05am, Thursday, 17'th Feb 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platf
IMV Doses First Patient in the Mid-Stage Study With Keytruda
02:16pm, Thursday, 13'th Jan 2022 Zacks Investment Research
IMV (IMV) doses first patient in the phase II study evaluating lead compound, maveropepimut-S (MVP-S), in combination with Keytruda
IMV Doses First Patient in the Mid-Stage Study With Keytruda
10:46am, Thursday, 13'th Jan 2022
IMV (IMV) doses first patient in the phase II study evaluating lead compound, maveropepimut-S (MVP-S), in combination with Keytruda
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
01:30pm, Wednesday, 12'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug
Biogen, Inc. (NASDAQ: BIIB) shares
IMV Inc. to Present at Two Upcoming Investor Events
07:05am, Wednesday, 05'th Jan 2022
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. to Present at Two Upcoming Investor Events
IMV Inc Shares Near 52-Week Low - Market Mover
05:18am, Thursday, 30'th Dec 2021 Kwhen Finance
IMV Inc (IMV) shares closed today at 0.8% above its 52 week low of $1.21, giving the company a market cap of $101M. The stock is currently down 59.7% year-to-date, down 62.8% over the past 12 months, and up 63.2% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 19.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
Indices - IMV Rating Reiterated by Raymond James
06:21am, Friday, 24'th Dec 2021 Business Mag
IMV s stock had its market perform rating reiterated by equities researchers at Raymond James in a research report issued to clients and investors on Wednesday, Analyst
IMV (NASDAQ:IMV) PT Set at $1.75 by Raymond James
07:14pm, Wednesday, 22'nd Dec 2021 Dakota Financial News
IMV (NASDAQ:IMV) received a $1.75 price objective from equities research analysts at Raymond James in a report issued on Wednesday, BayStreet.CA reports. The brokerage currently has a “market perform” rating on the stock. Raymond James’ price target points to a potential upside of 26.81% from the company’s previous close. IMV has been the topic of […]
IMV Names Andrew Hall CEO - Quick Facts
12:29pm, Wednesday, 22'nd Dec 2021 Business Insider Markets
(RTTNews) - IMV Inc. (IMV, IMV.TO) said its Board has appointed Andrew Hall to the role of Chief Executive Office and Director of the Board, effective January 1, 2022. He has more than 20 years of executive experience in biopharmaceuticals and life sciences. In November, 2020, Andrew Hall was appointed to the newly created role of Chief
IMV makes interim CEO Andrew Hall permanent
12:09pm, Wednesday, 22'nd Dec 2021 Seeking AlphaZacks: Analysts Expect IMV Inc. (NASDAQ:IMV) Will Post Earnings of -$0.13 Per Share
09:14pm, Sunday, 12'th Dec 2021 Dakota Financial News
Brokerages predict that IMV Inc. (NASDAQ:IMV) will announce ($0.13) earnings per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for IMVs earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.14). IMV reported earnings of ($0.11) per share in the same quarter last year, which indicates a []
Islamic Vision Mission to construct K15 billion Mufti-Abbas University in Mangochi
02:30am, Saturday, 11'th Dec 2021 Nyasa Times
The Islamic Vision Mission (IMV) on Wednesday launched the construction of an Islamic university college to be called Mufti Abbas Center for Excellence University in Mangochi which will require about K15 Billion to complete in five years. The IMV launched the project in Mangochi town where Minister of Home Land Security, Richard Chimwendo Banda said [] The post Islamic Vision Mission to construct K15 billion Mufti-Abbas University in Mangochi appeared first on Malawi Nyasa Times - News from Malawi about Malawi .